3 news items
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
AEYE
ALLR
BPTS
15 Apr 24
sharply in today’s pre-market trading after the company announced that it sold its majority
Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
KA
8 Apr 24
on discovering and developing potentially differentiated immunotherapies that address the major challenges with current cancer therapy. The company's immuno
Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium
KA
22 Feb 24
potentially differentiated immunotherapies that address the major challenges with current cancer therapy. The company's immuno-oncology pipeline includes
- Prev
- 1
- Next